Neuroimaging, primarily magnetic resonance imaging (MRI), is crucial for the diagnosis, evaluation of pathophysiology and assessment of treatment efficacy in encephalopathy syndromes. Key MRI findings essential for diagnosis include specific patterns such as delayed subcortical reduced diffusion (bright tree appearance) in acute encephalopathy with biphasic seizure and late reduced diffusion (AEDS), reversible splenial lesions with homogeneously reduced diffusion for mild encephalitis/encephalopathy with a reversible splenial lesion (MERS), and symmetric hemorrhagic thalamic lesions for acute necrotizing encephalopathy (ANE). Identification of location of focal or diffuse T2/FLAIR hyperintensity or change in T1 signal can be immediately suggestive of specific disease. Furthermore, several advanced MRI techniques are valuable for suggesting or diagnosis. These include diffusion-weighted imaging (DWI) for characterizing cerebral edema, arterial spin labeling (ASL) for evaluating cerebral perfusion, and magnetic resonance spectroscopy (MRS) for assessing metabolic abnormalities. MRI is a crucial tool for diagnosing and assessing the severity of encephalopathy, which is a broad term describing various diseases that manifest as nonspecific brain dysfunction. MRI when alternated, can reveal various patterns of damage, such as edema (swelling) or changes in diffusion, which can help pinpoint the underlying cause and guide treatment. The imaging findings, combined with clinical and laboratory data, are essential for accurate diagnosis and management.